SCHEMBL31335474

SCHEMBL31335474

COc1ccc(CSc2ccc3c(c2)nc(Cl)n3C)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAOB P27338 3/20 0.48
▸ APP P05067 2/20 0.47
▸ ALDH1A1 P00352 2/20 0.46
▸ NPC1 O15118 2/20 0.46
▸ RAB9A P51151 2/20 0.46
▸ SMN1; SMN2 Q16637 2/20 0.46
▸ KDM4E B2RXH2 1/20 0.46
▸ TP53 P04637 1/20 0.46
▸ HSD17B10 Q99714 1/20 0.46
▸ MAOA P21397 2/20 0.45
▸ DCTPP1 Q9H773 2/20 0.43
▸ CYP1A2 P05177 1/20 0.42
▸ CYP2E1 P05181 1/20 0.42
▸ CYP3A4 P08684 1/20 0.42
▸ CYP2C8 P10632 1/20 0.42
▸ CYP2D6 P10635 1/20 0.42
▸ CYP2C9 P11712 1/20 0.42
▸ CYP2B6 P20813 1/20 0.42
▸ CYP2C19 P33261 1/20 0.42
▸ PTGDR2 Q9Y5Y4 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31180506 0.79 MAOB (0.49) MAOBAPPALDH1A1NPC1RAB9A
SCHEMBL25443596 0.78 ALDH1A1 (0.55) ALDH1A1NPC1RAB9ASMN1; SMN2KDM4E
SCHEMBL28463252 0.78 ALDH1A1 (0.51) ALDH1A1NPC1RAB9ASMN1; SMN2KDM4E
SCHEMBL32661906 0.78 MAOB (0.50) MAOBAPPALDH1A1NPC1RAB9A
SCHEMBL31335383 0.77 MAOB (0.41) MAOBAPPALDH1A1NPC1RAB9A
SCHEMBL30438880 0.76 MAOB (0.51) MAOBAPPALDH1A1NPC1RAB9A
SCHEMBL25702594 0.76 MAOB (0.51) MAOBAPPALDH1A1NPC1RAB9A
SCHEMBL13605680 0.74 APP (0.43) MAOBAPPALDH1A1NPC1RAB9A
SCHEMBL32662290 0.74 NPC1 (0.46) MAOBAPPALDH1A1NPC1RAB9A
SCHEMBL13605681 0.74 MAOB (0.44) MAOBAPPALDH1A1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4719605-A1 CHEMICAL COMPOUNDS AND USES THEREOF GlaxoSmithKline Intellectual Property (No.4) Limited (GB) 2026-04-08 — — EP disclosed
US-20260015321-A1 CHEMICAL COMPOUNDS AND USES THEREOF GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.4) LIMITED (GB) 2026-01-15 — — US disclosed
WO-2024246862-A1 CHEMICAL COMPOUNDS AND USES THEREOF GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO. 4) LIMITED (GB) 2024-12-05 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260015321-A1 CHEMICAL COMPOUNDS AND USES THEREOF WRN, MSH2, MSH6 MAOB 2261/4885APP 4357/4885ALDH1A1 1151/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback